v3.25.2
Restatement of Previously Issued Financial Statements - Schedule of Consolidated Statements of Cash Flows (Details) - USD ($)
 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Schedule of Consolidated Statements of Cash Flows [Line Items]    
Net loss $ (17,815,307) $ (1,841,899)
Adjustments to reconcile net loss to net cash used in operating activities.    
Amortization expense 103
Depreciation expense 27,113 103
Changes in operating assets and liabilities    
Prepaid expenses 145,106 (77,215)
Advance to a related company 98,771 10,289
Deposits 102,327 (127,664)
Other receivables (45,306) (34,183)
Interests payable 23,657 23,380
Other payables and accrued expenses 702,538 160,597
Payable to directors 2,296,915
Net cash (used in) provided by operating activities (3,026,529) 410,323
Cash flows from investing activities:    
Purchases of property and equipment (1,438,033) (1,598)
Net cash used in investing activities (1,438,033) (1,598)
Cash flows from financing activities:    
Payments of deferred merger costs   (700,810)
Net cash provided by (used in) financing activities 4,706,973 (700,810)
Effect of exchange rate changes 104,814 68,394
Net change in cash 347,225 (223,691)
Cash, beginning of the year 1,430 225,121
Cash, end of the year 348,655 1,430
As previously reported [Member]    
Schedule of Consolidated Statements of Cash Flows [Line Items]    
Net loss   (2,340,661)
Adjustments to reconcile net loss to net cash used in operating activities.    
Amortization expense   431,593
Depreciation expense   103
Changes in operating assets and liabilities    
Prepaid expenses   (77,215)
Advance to a related company   10,289
Deposits   (127,664)
Other receivables   (34,183)
Interests payable   23,380
Other payables and accrued expenses   119,147
Payable to directors   1,704,724
Net cash (used in) provided by operating activities   (290,487)
Cash flows from investing activities:    
Purchases of property and equipment   (1,598)
Net cash used in investing activities   (1,598)
Cash flows from financing activities:    
Payments of deferred merger costs  
Net cash provided by (used in) financing activities  
Effect of exchange rate changes   68,394
Net change in cash   (223,691)
Cash, beginning of the year 1,430 225,121
Cash, end of the year   1,430
Adjustments [Member]    
Schedule of Consolidated Statements of Cash Flows [Line Items]    
Net loss   498,762
Adjustments to reconcile net loss to net cash used in operating activities.    
Amortization expense   (431,593)
Depreciation expense  
Changes in operating assets and liabilities    
Prepaid expenses  
Advance to a related company  
Deposits  
Other receivables  
Interests payable  
Other payables and accrued expenses   41,450
Payable to directors   592,191
Net cash (used in) provided by operating activities   700,810
Cash flows from investing activities:    
Purchases of property and equipment  
Net cash used in investing activities  
Cash flows from financing activities:    
Payments of deferred merger costs   (700,810)
Net cash provided by (used in) financing activities   (700,810)
Effect of exchange rate changes  
Net change in cash  
Cash, beginning of the year
Cash, end of the year